Search Documents
CSOP Industry Day Q and A.pdf
Posted: June 8, 2020
• Type: .pdf
• Size: 0.18MB
Submit Questions to Government Officer Anonymously
Place your question(s) below. One of our analysts will anonymously submit the question(s) within 8 hours and provide any responses via email once received.
Question & Answer Assistant
Hello! Please let me know your question about this document. I will answer based on the related documents for this opportunity.
Some suggestions:
I'd like to anonymously submit a question to the procurement officer(s)
Loading
Overview
Related Opportunity
Related Agency
Profiled People
Summary
compilation of responses provided by the Department of Homeland Security (DHS) to industry questions raised during the CSOP COVID-19 Industry Day webinar held on June 3, 2020. The key points covered include clarifications on proposal requirements, such as the proposal length not including attachments and the flexibility for proposals to be less than 12 pages if they address the technical questionnaire adequately. Additionally, information was shared regarding funding for development projects under the Commercial Solutions Opening Pilot Program authority, potential changes to fiscal year schedules due to COVID-19, and the process for updating and resubmitting proposals.
Furthermore, the document addresses inquiries related to awards allocation, types of innovative commercial products sought by DHS, intellectual property rights negotiations, contact tracing procedures, ongoing screenings for COVID-19 antibodies, procurement of testing technology kits, and considerations for frontline staff testing and screening.
It also touches on topics like unsolicited proposals submission procedures, interest in noncontact TSA passenger screening solutions, R&D funding possibilities for COVID-19 response tests, and the focus of CSOP on pandemic recovery solutions. The responses indicate a dynamic and evolving landscape as DHS evaluates various proposals and technologies to address current and future challenges posed by the pandemic.
Furthermore, the document addresses inquiries related to awards allocation, types of innovative commercial products sought by DHS, intellectual property rights negotiations, contact tracing procedures, ongoing screenings for COVID-19 antibodies, procurement of testing technology kits, and considerations for frontline staff testing and screening.
It also touches on topics like unsolicited proposals submission procedures, interest in noncontact TSA passenger screening solutions, R&D funding possibilities for COVID-19 response tests, and the focus of CSOP on pandemic recovery solutions. The responses indicate a dynamic and evolving landscape as DHS evaluates various proposals and technologies to address current and future challenges posed by the pandemic.
Show All